Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
Provided By Globe Newswire
Last update: Nov 8, 2021
HOUSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced financial results for the third quarter ended September 30, 2021 and provided a business update.
